33 Chimerix's (CMRX) recently approved "weaponized smallpox" vaccine (Brincidofovir) has previously failed TWO different Phase 3 trials with all-cause deaths in the treatment group occurring at 150% of the rate for placebo group, 15% versus 10%. (www.fiercebiotech.com) posted 3 years ago by Error_usernotfound 3 years ago by Error_usernotfound +33 / -0 8 comments share 8 comments share save hide report block hide replies
All with BARPA, the biomedical version of DARPA.
SIGA also had an approved smallpox medication TPOXX approved 2018.
Haven't started down the Siga rabbit hole yet. Still digging up stuff on Chimerix.